Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (531-540 of 560) with videos related to

Pageof 56
Sort By:
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 WorkshopM Nap, A Vitali, K Nustad, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimensDaniel W Cramer, Robert C Bast, Christine D Berg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and MedicineK Nustad, R C Bast, T J Brien, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2019
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast CancersHailing Yang, Zhang Shu, Yongying Jiang, et al.
British Journal of Cancer|January 10, 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerChae Young Han, Jacob S Bedia, Wei-Lei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical ValidationSandra L Grimm, Menuka Karki, Kyle A Blum, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2020
Targeting progesterone signaling prevents metastatic ovarian cancerOlga Kim, Eun Young Park, Sun Young Kwon, et al.
Gynecologic Oncology|April 11, 2012
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancerSiqing Fu, Bryan T Hennessy, Chaan S Ng, et al.
Pageof 56

Showing results (531-540 of 560) with videos related to

Sort By:
Pageof 56
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 WorkshopM Nap, A Vitali, K Nustad, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimensDaniel W Cramer, Robert C Bast, Christine D Berg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and MedicineK Nustad, R C Bast, T J Brien, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2019
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast CancersHailing Yang, Zhang Shu, Yongying Jiang, et al.
British Journal of Cancer|January 10, 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerChae Young Han, Jacob S Bedia, Wei-Lei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical ValidationSandra L Grimm, Menuka Karki, Kyle A Blum, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2020
Targeting progesterone signaling prevents metastatic ovarian cancerOlga Kim, Eun Young Park, Sun Young Kwon, et al.
Gynecologic Oncology|April 11, 2012
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancerSiqing Fu, Bryan T Hennessy, Chaan S Ng, et al.
Pageof 56